Abu Saleh Md Moin

InstitutionHamad Bin Khalifa University (HBKU)
AddressDoha
Qatar
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 13 Covid-19 publications, with a maximum of 3 publications in March 2021
    All Publications
    Bar chart showing 22 publications over 6 distinct years, with a maximum of 8 publications in 2021
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Moin ASM, Al-Qaissi A, Sathyapalan T, Atkin SL, Butler AE. Type 2 Diabetes Coagulopathy Proteins May Conflict With Biomarkers Reflective of COVID-19 Severity. Front Endocrinol (Lausanne). 2021; 12:658304. PMID: 34248840.
      Citations:    Translation:Humans
    2. Moin ASM, Al-Qaissi A, Sathyapalan T, Atkin SL, Butler AE. Soluble Neuropilin-1 Response to Hypoglycemia in Type 2 Diabetes: Increased Risk or Protection in SARS-CoV-2 Infection? Front Endocrinol (Lausanne). 2021; 12:665134. PMID: 34248841.
      Citations:    Translation:Humans
    3. Moin ASM, Al-Qaissi A, Sathyapalan T, Atkin SL, Butler AE. Platelet Protein-Related Abnormalities in Response to Acute Hypoglycemia in Type 2 Diabetes. Front Endocrinol (Lausanne). 2021; 12:651009. PMID: 33859620.
      Citations: 1     Translation:HumansCells
    4. Moin ASM, Sathyapalan T, Diboun I, Atkin SL, Butler AE. Identification of macrophage activation-related biomarkers in obese type 2 diabetes that may be indicative of enhanced respiratory risk in COVID-19. Sci Rep. 2021 03 19; 11(1):6428. PMID: 33742062.
      Citations: 1     Fields:    Translation:HumansCTClinical Trials
    5. Moin ASM, Sathyapalan T, Atkin SL, Butler AE. Correction to: COVID-19 biomarkers for severity mapped to polycystic ovary syndrome. J Transl Med. 2021 Mar 15; 19(1):106. PMID: 33722238.
      Citations:    Fields:    
    6. Moin ASM, Sathyapalan T, Butler AE, Atkin SL. Vitamin D Association With Macrophage-Derived Cytokines in Polycystic Ovary Syndrome: An Enhanced Risk of COVID-19 Infection? Front Endocrinol (Lausanne). 2021; 12:638621. PMID: 33716989.
      Citations: 1     Translation:HumansCells
    7. Moin ASM, Nandakumar M, Sathyapalan T, Atkin SL, Butler AE. Biomarkers of COVID-19 severity may not serve patients with polycystic ovary syndrome. J Transl Med. 2021 02 11; 19(1):63. PMID: 33573655.
      Citations:    Fields:    Translation:Humans
    8. Moin ASM, Sathyapalan T, Atkin SL, Butler AE. The relationship of soluble neuropilin-1 to severe COVID-19 risk factors in polycystic ovary syndrome. Metabol Open. 2021 Mar; 9:100079. PMID: 33521617.
      Citations: 2     
    9. Moin ASM, Sathyapalan T, Atkin SL, Butler AE. COVID-19 biomarkers for severity mapped to polycystic ovary syndrome. J Transl Med. 2020 12 22; 18(1):490. PMID: 33353554.
      Citations: 3     Fields:    
    10. Moin ASM, Al-Qaissi A, Sathyapalan T, Atkin SL, Butler AE. Mapping of type 2 diabetes proteins to COVID-19 biomarkers: A proteomic analysis. Metabol Open. 2021 Mar; 9:100074. PMID: 33364597.
      Citations: 1     
    11. Moin ASM, Al-Qaissi A, Sathyapalan T, Atkin SL, Butler AE. Do biomarkers of COVID-19 severity simply reflect a stress response in type 2 diabetes: Biomarker response to hypoglycemia. Metabolism. 2021 01; 114:154417. PMID: 33157081.
      Citations: 2     Fields:    Translation:HumansPHPublic Health
    12. Moin ASM, Sathyapalan T, Atkin SL, Butler AE. Renin-Angiotensin System overactivation in polycystic ovary syndrome, a risk for SARS-CoV-2 infection? Metabol Open. 2020 Sep; 7:100052. PMID: 32838280.
      Citations: 5     
    13. Moin ASM, Al-Qaissi A, Sathyapalan T, Atkin SL, Butler AE. Renin-Angiotensin System Overactivation in Type 2 Diabetes: A Risk for SARS-CoV-2 Infection? Diabetes Care. 2020 10; 43(10):e131-e133. PMID: 32616611.
      Citations: 3     Fields:    
    Moin's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (81)
    Explore
    _
    Co-Authors (6)
    Explore
    _
    Similar People (60)
    Explore
    _